Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7533)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fukui A, Kawabe N, Hashimoto S, Murao M, Nakano T, Shimazaki H, Kan T, Nakaoka K, Ohki M, Takagawa Y, Takamura T, Kamei H, Yoshioka K. Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease. World J Hepatol 2015; 7(27): 2749-2756 [PMID: 26644818 DOI: 10.4254/wjh.v7.i27.2749] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i27/2749.htm |
| Number | Citing Articles |
| 1 |
Gregor Lorbek, Žiga Urlep, Damjana Rozman. Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver disease. Pharmacogenomics 2016; 17(11): 1273 doi: 10.2217/pgs-2016-0047
|
| 2 |
Yoshio Sumida, Masato Yoneda, Yuya Seko, Hirokazu Takahashi, Nagisa Hara, Hideki Fujii, Yoshito Itoh, Masashi Yoneda, Atsushi Nakajima, Takeshi Okanoue. Role of vitamin E in the treatment of non-alcoholic steatohepatitis. Free Radical Biology and Medicine 2021; 177: 391 doi: 10.1016/j.freeradbiomed.2021.10.017
|
| 3 |
Margalida Monserrat-Mesquida, Cristina Bouzas, Catalina M. Mascaró, Silvia Tejada, Antoni Sureda. Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD). Fermentation 2023; 9(4): 395 doi: 10.3390/fermentation9040395
|
| 4 |
George Agyapong, Farzaneh Dashti, Bubu A. Banini. Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies. Annals of the New York Academy of Sciences 2023; 1526(1): 16 doi: 10.1111/nyas.15012
|
| 5 |
José Ignacio Martínez-Montoro, Isabel Cornejo-Pareja, Ana María Gómez-Pérez, Francisco J. Tinahones. Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease. Nutrients 2021; 13(11): 4077 doi: 10.3390/nu13114077
|
| 6 |
H.G. Ağalar. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; : 175 doi: 10.1016/B978-0-12-816488-4.00009-7
|
| 7 |
Mengyao Zhao, Shumin Chen, Xiaoguo Ji, Xin Shen, Jiangshan You, Xinyi Liang, Hao Yin, Liming Zhao. Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease. Pharmacological Research 2021; 166: 105517 doi: 10.1016/j.phrs.2021.105517
|
| 8 |
Maryam Abbasi, Effat Bambaeichi, Mehdi Nematbakhsh. Co-administration of vitamin C or estradiol with aerobic exercise on liver oxidative stress and enzymes in ovariectomized rat. Sport Sciences for Health 2017; 13(3): 521 doi: 10.1007/s11332-017-0369-2
|
| 9 |
Xinyu Shi, Yalan Xiong, Hualing Song, Fen Rong, Nan Tang, Leping Zhu, Shenyu Li, Jianying Wang, Lei Zhang, Shengfu You, Guang Ji, Baocheng Liu, Na Wu. Progress and hotspot of diet or exercise therapy in the treatment of non-alcoholic fatty liver disease. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1326092
|
| 10 |
Tomasz Charytoniuk, Krzysztof Drygalski, Karolina Konstantynowicz-Nowicka, Klaudia Berk, Adrian Chabowski. Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials. Nutrition 2017; 34: 108 doi: 10.1016/j.nut.2016.09.001
|
| 11 |
Shufei Zang, Jin Chen, Yu Song, Lang Bai, Jinjun Chen, Xiaoling Chi, Fangping He, Huiping Sheng, Jing Wang, Shilong Xie, Wen Xie, Yongfeng Yang, Jing Zhang, Minghua Zheng, Zhengsheng Zou, Bingyuan Wang, Junping Shi. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design. Advances in Therapy 2018; 35(2): 218 doi: 10.1007/s12325-018-0670-8
|
| 12 |
Anna Jeznach-Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka-Senczyna, Iwona Boniecka, Urszula Shahnazaryan, Alina Kuryłowicz. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. Medicina 2019; 55(5): 166 doi: 10.3390/medicina55050166
|
| 13 |
Kanokwan Jarukamjorn, Waranya Chatuphonprasert, Nattharat Jearapong, Charatda Punvittayagul, Rawiwan Wongpoomchai. Tetrahydrocurcumin attenuates phase I metabolizing enzyme-triggered oxidative stress in mice fed a high-fat and high-fructose diet. Journal of Functional Foods 2019; 55: 117 doi: 10.1016/j.jff.2019.02.021
|
| 14 |
Mehtap Civelek, Maren C. Podszun. Genetic Factors Associated with Response to Vitamin E Treatment in NAFLD. Antioxidants 2022; 11(7): 1284 doi: 10.3390/antiox11071284
|
| 15 |
Muhammad Amjad Pervez, Dilshad Ahmed Khan, Shakeel Ahmed Mirza, Atiq Ur Rehman Slehria, Uzma Nisar, Mohammad Aamir. Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial. Complementary Therapies in Medicine 2022; 70: 102866 doi: 10.1016/j.ctim.2022.102866
|